Stocks and InvestingStocks and Investing
Fri, September 22, 2023
Thu, September 21, 2023
Wed, September 20, 2023
Tue, September 19, 2023

Shawn Egan Initiated (ARWR) at Hold and Held Target at $33 on, Sep 19th, 2023


Published on 2024-10-28 06:28:31 - WOPRAI, Shawn Egan
  Print publication without navigation


Shawn Egan of Citigroup, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold and Held Target at $33 on, Sep 19th, 2023.

Shawn has made no other calls on ARWR in the last 4 months.



There are 7 other peers that have a rating on ARWR. Out of the 7 peers that are also analyzing ARWR, 0 agree with Shawn's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Shawn


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $90 on, Wednesday, August 9th, 2023
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $47 on, Tuesday, August 8th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $60 on, Tuesday, August 8th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $60 on, Tuesday, August 8th, 2023
  • Brendan Smith of "TD Cowen" Initiated at Buy on, Friday, July 21st, 2023
  • Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $55 on, Thursday, July 20th, 2023
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $59 on, Friday, June 2nd, 2023